Top Yale lab spawns new company focused on development of glucosepane-cleaving drugs.
San Francisco based biotech start-up Revel Pharmaceuticals has announced itself to the...
Major new prize announced to help identify how cells intentionally self-organise and communicate; George Church part of judging panel.
The origin of life is often...
Going public as a Longevity stock is all about good timing and good clinical results: Some stand-out performers have experienced a volatile year.
The world’s...
Acquisition of Human Longevity’s oncology division for $37m demonstrates both the opportunities and challenges for Longevity investing.
On Friday, NeoGenomics announced that it had agreed...
A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society.
The world is...
Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...
BIOFABICS brings custom design tools to biofabrication.
While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...
